Table 4 Clinico-pathological associations of ATM mutant breast cancer patients.

From: Identification and characterization of ATM founder mutation in BRCA-negative breast cancer patients of Arab ethnicity

Clinico-pathological variables

ATM mutant (n = 6)

ATM wildtype (n = 709)

p value

n (%)

n (%)

Age at diagnosis, years

Ā Mean ± SD

45 ± 12.7

41.2 ± 9.8

Ā 

Ā Median (range)

39 (32 – 63)

39.7 (13 – 84)

Ā 

  ≤ 50

4 (66.7)

610 (86.0)

0.2027

  > 50

2 (33.3)

99 (14.0)

Ā 

Family history of breast cancer

Ā No

2 (33.3)

580 (81.8)

0.0127

Ā Yes

4 (66.7)

129 (18.2)

Ā 

Bilateral breast cancer

Ā Yes

0

12 (1.7)

1.0000

Ā No

6 (100.0)

697 (98.3)

Ā 

Lymph node status

Ā Negative

2 (33.3)

258 (37.5)

1.0000

Ā Positive

4 (66.7)

430 (62.5)

Ā 

Distant metastasis

Ā Absent

5 (83.3)

623 (90.5)

0.4522

Ā Present

1 (16.7)

65 (9.5)

Ā 

Stage

Ā I

0

98 (14.2)

0.7233

Ā II

3 (20.0)

282 (41.0)

Ā 

Ā III

2 (33.3)

243 (35.3)

Ā 

Ā IV

1 (16.7)

65 (9.5)

Ā 

Histologic grade

Ā Well differentiated

0

48 (7.1)

0.2026

Ā Moderately differentiated

5 (83.3)

317 (47.0)

Ā 

Ā Poorly differentiated

1 (16.7)

309 (45.9)

Ā 

Estrogen receptor status

Ā Positive

5 (83.3)

388 (57.2)

0.2479

Ā Negative

1 (16.7)

290 (42.8)

Ā 

Progesterone receptor status

Ā Positive

4 (66.7)

356 (52.6)

0.6889

Ā Negative

2 (33.3)

321 (47.4)

Ā 

Her-2 neu status

Ā Positive

2 (33.3)

231 (34.6)

1.0000

Ā Negative

4 (66.7)

437 (65.4)

Ā